Literature DB >> 4030433

pH distribution in human tumors.

A J Thistlethwaite, D B Leeper, D J Moylan, R E Nerlinger.   

Abstract

The effectiveness of hyperthermia in tumor therapy may depend on a lower extracellular pH of tumor compared to that of normal tissue. A technique for measuring extracellular pH in human tumors has been devised to test the usefulness of this parameter as prognostic indicator of tumor hyperthermia response. In a preliminary study 50 of 53 pH readings from 14 human tumors (both heated and unheated) were below normal physiological pH. Tumor pH values ranged between 5.55-7.69 (average for unheated tumors 6.81 +/- 0.09, SEM, only one determination was above 7.40). Although there was considerable heterogeneity of pH within tumors, the accuracy and drift of the 21 gauge needle electrode were not a problem. Fifteen minutes were required for pH stabilization after insertion of an 18 gauge open-ended catheter, and less than 5 min for equilibration after electrode insertion into the catheter. A saline wheal was used for anesthesia to preclude modification of pH by anesthetics. Central portions of tumors were no more acidic than peripheral regions, but large tumors tended to be more acidic than small tumors. The pH of several tumors of various sizes and histologies was also determined immediately before subsequent treatment sessions. These measurements were made by reinsertion of catheters in approximately the same locations at each session. The trend appeared to be that pH increased with the number of treatment sessions. Measurements of pH were made in four patients immediately prior to and at the termination of a heating session (same locations since catheter remained in place during heating sessions). Three of the four tumors showed increased pH readings of 0.25-0.54 units during heating. However, none of the four tumors achieved temperatures exceeding 42 degrees C. The pH measurement technique developed provides a safe and relatively easy method for determining extracellular pH in human tumors. There appears to be a correlation of pH values with tumor size, treatment session, and possibly blood flow.

Entities:  

Mesh:

Year:  1985        PMID: 4030433     DOI: 10.1016/0360-3016(85)90217-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

Review 1.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

Review 2.  InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

Authors:  Feifan Zhou; Xiaosong Li; Mark F Naylor; Tomas Hode; Robert E Nordquist; Luciano Alleruzzo; Joseph Raker; Samuel S K Lam; Nan Du; Lei Shi; Xiuli Wang; Wei R Chen
Journal:  Cancer Lett       Date:  2015-01-26       Impact factor: 8.679

3.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

4.  Iron Oxide Hyperthermia And Radiation Cancer Treatment.

Authors:  Sm Cassim; Aj Giustini; Aa Petryk; Ra Strawbridge; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

5.  Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue.

Authors:  E Lavie; D L Hirschberg; G Schreiber; K Thor; L Hill; I Hellstrom; K E Hellstrom
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Improved pH measurements with a single PARACEST MRI contrast agent.

Authors:  Vipul R Sheth; Guanshu Liu; Yuguo Li; Mark D Pagel
Journal:  Contrast Media Mol Imaging       Date:  2012 Jan-Feb       Impact factor: 3.161

7.  Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy.

Authors:  Vikash P Chauhan; Ivy X Chen; Rong Tong; Mei Rosa Ng; John D Martin; Kamila Naxerova; Michelle W Wu; Peigen Huang; Yves Boucher; Daniel S Kohane; Robert Langer; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

8.  An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells.

Authors:  B Müller; B Fischer; W Kreutz
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

9.  Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles.

Authors:  Rong Liu; Denis M Gilmore; Kimberly Ann V Zubris; Xiaoyin Xu; Paul J Catalano; Robert F Padera; Mark W Grinstaff; Yolonda L Colson
Journal:  Biomaterials       Date:  2012-12-08       Impact factor: 12.479

10.  Effect of pH and moderate hyperthermia on doxorubicin, epirubicin and aclacinomycin A cytotoxicity for Chinese hamster ovary cells.

Authors:  L Kleeberger; E M Röttinger
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.